These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 35676009
1. Body mass index, proteinuria and total lymphocyte counts in predicting treatment responses among ART naïve individuals with HIV initiated on antiretroviral treatment in Dar es Salaam, Tanzania, 2019: a cohort study. Munseri P, Jassely L, Tumaini B, Hertzmark E. BMJ Open; 2022 Jun 08; 12(6):e059193. PubMed ID: 35676009 [Abstract] [Full Text] [Related]
2. Long-term virological outcomes in women who started option B+ care during pregnancy for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania: a cohort study. Lyatuu GW, Mwashemele SZ, Urrio R, Naburi H, Kashmir N, Machumi L, Kibao A, Sellah Z, Ulenga N, Orsini N, Biberfeld G, Kilewo C, Ekström AM. Lancet HIV; 2021 May 08; 8(5):e256-e265. PubMed ID: 33581776 [Abstract] [Full Text] [Related]
3. Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania. Ngarina M, Kilewo C, Karlsson K, Aboud S, Karlsson A, Marrone G, Leyna G, Ekström AM, Biberfeld G. BMC Infect Dis; 2015 Apr 08; 15():175. PubMed ID: 25886277 [Abstract] [Full Text] [Related]
4. Better Virological Outcomes Among People Living With Human Immunodeficiency Virus (HIV) Initiating Early Antiretroviral Treatment (CD4 Counts ≥500 Cells/µL) in the HIV Prevention Trials Network 071 (PopART) Trial in South Africa. Fatti G, Grimwood A, Nachega JB, Nelson JA, LaSorda K, van Zyl G, Grobbelaar N, Ayles H, Hayes R, Beyers N, Fidler S, Bock P. Clin Infect Dis; 2020 Jan 16; 70(3):395-403. PubMed ID: 30877753 [Abstract] [Full Text] [Related]
5. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. Phillips AN, Staszewski S, Weber R, Kirk O, Francioli P, Miller V, Vernazza P, Lundgren JD, Ledergerber B, Swiss HIV Cohort Study, Frakfurt HIV Clinic Cohort, EuroSIDA Study Group. JAMA; 2001 Nov 28; 286(20):2560-7. PubMed ID: 11722270 [Abstract] [Full Text] [Related]
6. Sociodemographic and Clinical Predictors of Weight Gain During the First Year of Antiretroviral Therapy among Adults Living With HIV in Urban Tanzania. Chillo P, Muhihi A, Danaei G, Bakari M, Kwesigabo G, Njelekela M, Ulenga N, Fawzi WW, Mugusi F, Sudfeld CR. J Int Assoc Provid AIDS Care; 2024 Nov 28; 23():23259582241281010. PubMed ID: 39360426 [Abstract] [Full Text] [Related]
7. Mortality during the first 24 months after delivery in relation to CD4 T-lymphocyte levels and viral load in a cohort of breast-feeding HIV-1-infected women in Dar es Salaam, Tanzania. Kilewo C, Karlsson K, Swai A, Massawe A, Lyamuya E, Mhalu F, Biberfeld G. J Acquir Immune Defic Syndr; 2005 Apr 15; 38(5):598-602. PubMed ID: 15793372 [Abstract] [Full Text] [Related]
8. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings. Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS. Antivir Ther; 2003 Oct 15; 8(5):379-84. PubMed ID: 14640384 [Abstract] [Full Text] [Related]
9. An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy. Koethe JR, Jenkins CA, Shepherd BE, Stinnette SE, Sterling TR. Clin Infect Dis; 2011 Nov 15; 53(9):952-60. PubMed ID: 21946189 [Abstract] [Full Text] [Related]
10. Effect of schistosomiasis on the outcome of patients infected with HIV-1 starting antiretroviral therapy in rural Tanzania. Stete K, Glass TR, van Dam GJ, Ntamatungiro A, Letang E, de Dood CJ, Corstjens PLAM, Ndege R, Mapesi H, Kern WV, Hatz C, Weisser M, Utzinger J, Müller MC. PLoS Negl Trop Dis; 2018 Oct 15; 12(10):e0006844. PubMed ID: 30332404 [Abstract] [Full Text] [Related]
11. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality. Suárez-García I, Sobrino-Vegas P, Dalmau D, Rubio R, Iribarren JA, Blanco JR, Gutierrez F, Montero Alonso M, Bernal E, Vinuesa García D, Del Amo J, Cohort of the Spanish HIV Research Network (CoRIS). Addiction; 2016 Jul 15; 111(7):1235-45. PubMed ID: 26890155 [Abstract] [Full Text] [Related]
12. Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania. Mosha F, Muchunguzi V, Matee M, Sangeda RZ, Vercauteren J, Nsubuga P, Lyamuya E, Vandamme AM. BMC Public Health; 2013 Jan 15; 13():38. PubMed ID: 23320567 [Abstract] [Full Text] [Related]
13. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial. Mermin J, Ekwaru JP, Were W, Degerman R, Bunnell R, Kaharuza F, Downing R, Coutinho A, Solberg P, Alexander LN, Tappero J, Campbell J, Moore DM. BMJ; 2011 Nov 09; 343():d6792. PubMed ID: 22074711 [Abstract] [Full Text] [Related]
14. Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals. Calkins KL, Lesko CR, Chander G, Moore RD, Lau B. J Acquir Immune Defic Syndr; 2018 Mar 01; 77(3):317-324. PubMed ID: 29210833 [Abstract] [Full Text] [Related]
15. Rate and predictors of HIV virological failure among adults on first-line antiretroviral treatment in Dar Es Salaam, Tanzania. Samizi FG, Panga OD, Mulugu SS, Gitige CG, Mmbaga EJ. J Infect Dev Ctries; 2021 Jun 30; 15(6):853-860. PubMed ID: 34242197 [Abstract] [Full Text] [Related]
16. Impact of age on CD4 recovery and viral suppression over time among adults living with HIV who initiated antiretroviral therapy in the African Cohort Study. Bahemana E, Esber A, Dear N, Ganesan K, Parikh A, Reed D, Maganga L, Khamadi S, Mizinduko M, Lwilla A, Mkondoo D, Mwaisanga G, Somi N, Owouth J, Maswai J, Kiweewa F, Iroezindu M, Ake JA, Crowell TA, Valcour VG, Polyak CS, AFRICOS Study Group. AIDS Res Ther; 2020 Nov 12; 17(1):66. PubMed ID: 33183355 [Abstract] [Full Text] [Related]
17. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, Battegay M, Vernazza P, Bernasconi E, Opravil M, Kaufmann D, Sudre P, Francioli P, Telenti A. JAMA; 1999 Dec 15; 282(23):2220-6. PubMed ID: 10605973 [Abstract] [Full Text] [Related]
18. Weight change at 1 mo of antiretroviral therapy and its association with subsequent mortality, morbidity, and CD4 T cell reconstitution in a Tanzanian HIV-infected adult cohort. Sudfeld CR, Isanaka S, Mugusi FM, Aboud S, Wang M, Chalamilla GE, Giovannucci EL, Fawzi WW. Am J Clin Nutr; 2013 Jun 15; 97(6):1278-87. PubMed ID: 23636235 [Abstract] [Full Text] [Related]
19. Prevalence of hepatitis B co-infection and response to antiretroviral therapy among HIV-infected patients in Tanzania. Hawkins C, Christian B, Ye J, Nagu T, Aris E, Chalamilla G, Spiegelman D, Mugusi F, Mehta S, Fawzi W. AIDS; 2013 Mar 27; 27(6):919-927. PubMed ID: 23196935 [Abstract] [Full Text] [Related]
20. Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda. Tumwegamire A, Fatch R, Emenyonu NI, Lodi S, Muyindike WR, Kekibiina A, Adong J, Ngabirano C, Beesiga B, Marson K, Golabi N, Kamya M, Chamie G, Hahn JA. PLoS One; 2024 Mar 27; 19(3):e0300508. PubMed ID: 38507431 [Abstract] [Full Text] [Related] Page: [Next] [New Search]